US 12030958
Compositions and methods of use of alpha-1 antitrypsin fusion polypeptides
granted A61KA61K38/57A61P
Quick answer
US patent 12030958 (Compositions and methods of use of alpha-1 antitrypsin fusion polypeptides) held by The Regents of the University of Colorado expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K38/57, A61P, A61P13/08, A61P15/10